Alexander Rudensky, Ph.D.
Alexander Rudensky is Chairman of the Immunology Program and Director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center (MSKCC), an Investigator with the Howard Hughes Medical Institute, and a Tri‐Institutional Professor at Dr. Rudensky's research is focused on the differentiation of regulatory T lymphocytes, and their role in the immune responses. His laboratory demonstrated a role for the transcription factor Foxp3 as a Treg cell lineage specification factor. Dr. Rudensky's work provided important insights into the fundamental role for regulatory T cells in immunological tolerance and in a variety of processes and pathologies including autoimmunity, allergy, transplantation, immunity to infections, pregnancy, tissue repair, and cancer.
Dr. Rudensky is an elected Member of the National Academy of Sciences, and National Academy of Medicine, and a Fellow of the American Academy of Arts and Sciences